Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3801–3850 of 34667
On February 28, 2025, Anthony Anderson notified National Rural Utilities Cooperative Finance Corporation (the “Company”) that he will resign from the Board of Directors of the Company effective March 1, 2025.
On March 5, 2025, the Board of Directors (the “Board”) of Olin Corporation (“Olin”) elected General Edward Daly to serve on Olin’s Board.
Also, on March 6, 2025, Renaud Faucher was elected to the Board of Directors of IPALCO by the unanimous written consent of IPALCO’s shareholders (the “Shareholders”), AES U.S. Investments, Inc. (“AES U.S. Investments”) and CDP Infrastructures Fund L.P. (“CDP”), a wholly-owned subsidiary of La Caisse de dépôt et placement du Québec (“CDPQ”).
Mr. Faucher was nominated by CDP to replace a prior CDP nominee, Frédéric Lesage.
On March 6, 2025, shortly after the Effective Time, Jennifer Pekman and Brendan Molloy were appointed as directors of the Company.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 6, 2025, shortly after the Effective Time, Jennifer Pekman and Brendan Molloy were appointed as directors of the Company.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 4, 2025, Samuel M. Gullo, a member of the Board of Directors (the “Board”) of Financial Institutions, Inc. (the “Company”) and the Board of Directors of the Company’s wholly-owned subsidiary, Five Star Bank, informed the Board of his decision not to stand for re-election at the 2025 Annual Meeting of Shareholders.
On March 3, 2025, the Board of Directors (the “Board”) of Innovex International, Inc. (the “Company”) appointed Mr. Will Donnell to serve as a Class II director, effective March 3, 2025, to fill the vacancy arising from the passing of Patrick Connelly.
the passing of Patrick Connelly
On March 6, 2025, the Board of Directors (the "Board") of Everest Group, Ltd. (the "Company") increased its size to ten members and elected John Howard to serve on the Board, effective immediately.
Neil G. Budnick, a Class I director on the board of directors (the “Board”) of Information Services Group, Inc. (the “Company”), notified the Company of his intent to retire as a Class I director, effective as of March 14, 2025.
The Board appointed Samuel L. Molinaro Jr. to serve as a Class I director of the Company, effective as March 14, 2025, with an initial term expiring at the Company’s 2026 annual meeting of stockholders.
elected Claire Aldridge, Ph.D., as a director of the Company, effective March 14, 2025
On March 5, 2025, Zheqing (Simon) Shen informed Nu Skin Enterprises, Inc. (the “Company”) that he has decided not to stand for re-election to the Company’s Board of Directors (the “Board”) at the Company’s 2025 Annual Meeting of Stockholders due to other professional commitments.
On March 5, 2025 (March 6, 2025 in Australia), the Board of Directors (the “Board”) of Anteris Technologies Global Corp. (the “Company”) appointed David St Denis as the Company’s President and as a Class II director of the Board, effective immediately.
On March 5, 2025, J. Hale Hoak (Hale) and Katherine Murray were appointed to the Board of Directors (the "Board") of Westwood Holdings Group, Inc. (“Westwood”), effective immediately.
On March 5, 2025, J. Hale Hoak (Hale) and Katherine Murray were appointed to the Board of Directors (the "Board") of Westwood Holdings Group, Inc. (“Westwood”), effective immediately.
On March 3, 2025, Aw Jeen Rong resigned from his position as Executive Director of Graphjet Technology (the “Company”), effective immediately.
On March 6, 2025, the board of directors (the “Board”) of the Company appointed Alec Cunningham and David Mounts Gonzales as members of the Board, effective March 7, 2025.
On March 6, 2025, the board of directors (the “Board”) of the Company appointed Alec Cunningham and David Mounts Gonzales as members of the Board, effective March 7, 2025.
On February 28, 2025, Richard Pilnik, who has been a member of the Board of Directors (the “Board”) of DiaMedica Therapeutics Inc. (the “Company”), for over 15 years, informed the Company of his decision to retire and not to stand for re-election at the Company’s 2025 Annual General Meeting of Shareholders (the “AGM”).
On March 3, 2025, Ronald P. Trout, an independent member of the Board of Managers (the “Board”) of Dorchester Minerals Management GP LLC (“DMMGP”), the general partner of Dorchester Minerals Management LP (together with DMMGP, the “General Partners”), the general partner of Dorchester Minerals, L.P. (the “Company”), informed the Board of his decision to retire from the Board at the end of his current term and not stand for re-election as a manager at the Company’s 2025 Annual Meeting of Limited Partners (the “2025 Annual Meeting”).
the Board appointed George James Tsunis as a Class I director in order to fill the newly created vacancy, effective as of March 6, 2025.
the Board of Directors (the “Board”) has elected Dr. Karen N. Madden, to join the Board effective February 28, 2025.
On February 28, 2025, the Board of Directors of The Davey Tree Expert Company (the “Company”) appointed Joseph E. McNeely to fill a vacancy on the Board, effective March 7, 2025.
On January 29, 2025, the Board of Directors of Isabella Bank Corporation (the "Corporation") appointed David B. Behen (age 55) to the Board of Directors of the Corporation and to the Board of Directors of Isabella Bank effective March 3, 2025.
On February 28, 2025, Roger Fradin notified the Company of his decision to resign as a director of the Board, effective immediately.
On March 4, 2025, the Board appointed Sujay Kango as a Class II director of the Company and as a member of the Compensation Committee of the Board (the “Compensation Committee”), effective immediately after close of business on March 4, 2025.
On March 4, 2025, Tomas Kiselak, a member of the Board of Directors (the “Board) of Dianthus Therapeutics, Inc. (the “Company”), notified the Company of his resignation from the Board effective as of the close of business on March 4, 2025.
On March 3, 2025, Peter Benz, a member of the Board of Directors (the “Board”) of Red Violet, Inc. (the “Company”) resigned effective March 4, 2025 from the Board and its committees to pursue other business commitments.
On March 4, 2025, the Company’s Board appointed Greg Strakosch to the Board, effective immediately to fill the vacancy created by Mr. Benz’s resignation.
elected William L. Tyson as a director to fill the vacancy created by the expansion in the size of the Board, effective immediately.
On the Exchange Effective Date, Paul Weibel notified the Company of his resignation from the Board of Directors of the Company (the “Board”), effective on such date.
On the Exchange Effective Date, the Board appointed Curtis L. Hebert, Jr., as a director, effective immediately
resignations of Pierangelo Negri as a director
On March 5, 2025, the Board of Directors (“Board”) of Micron Technology, Inc. (the “Company”) appointed Anna Christine Simons and Teyin Mark Liu as members of the Board.
On March 5, 2025, the Board of Directors (“Board”) of Micron Technology, Inc. (the “Company”) appointed Anna Christine Simons and Teyin Mark Liu as members of the Board.
On March 3, 2025, Phillip A. Sharp, Ph.D. informed the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”) of his retirement from the Board, effective as of May 8, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.